Michael A Mussallem's most recent trade in Edwards Lifesciences Corp was a trade of 29,350 Common Stock done at an average price of $36.8 . Disclosure was reported to the exchange on May 2, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Edwards Lifesciences Corp | Michael A. Mussallem | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.75 per share. | 02 May 2024 | 29,350 | 33,835 (0%) | 0% | 36.8 | 1,078,613 | Common Stock |
| Edwards Lifesciences Corp | Michael A. Mussallem | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 May 2024 | 29,350 | 0 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Michael A. Mussallem | Director | Sale of securities on an exchange or to another person at price $ 84.59 per share. | 02 May 2024 | 17,143 | 4,485 (0%) | 0% | 84.6 | 1,450,126 | Common Stock |
| Edwards Lifesciences Corp | Michael A. Mussallem | Director | Sale of securities on an exchange or to another person at price $ 85.02 per share. | 02 May 2024 | 12,207 | 21,628 (0%) | 0% | 85.0 | 1,037,839 | Common Stock |
| Edwards Lifesciences Corp | Michael A. Mussallem | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.75 per share. | 04 Apr 2024 | 29,350 | 33,835 (0%) | 0% | 36.8 | 1,078,613 | Common Stock |
| Edwards Lifesciences Corp | Michael A. Mussallem | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Apr 2024 | 29,350 | 29,350 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Michael A. Mussallem | Director | Sale of securities on an exchange or to another person at price $ 92.70 per share. | 04 Apr 2024 | 16,618 | 4,485 (0%) | 0% | 92.7 | 1,540,489 | Common Stock |
| Edwards Lifesciences Corp | Michael A. Mussallem | Director | Sale of securities on an exchange or to another person at price $ 91.54 per share. | 04 Apr 2024 | 9,820 | 21,103 (0%) | 0% | 91.5 | 898,923 | Common Stock |
| Edwards Lifesciences Corp | Michael A. Mussallem | Director | Sale of securities on an exchange or to another person at price $ 93.72 per share. | 04 Apr 2024 | 2,712 | 30,923 (0%) | 0% | 93.7 | 254,169 | Common Stock |
| Edwards Lifesciences Corp | Michael A. Mussallem | Director | Sale of securities on an exchange or to another person at price $ 94.19 per share. | 04 Apr 2024 | 200 | 33,635 (0%) | 0% | 94.2 | 18,838 | Common Stock |
| Edwards Lifesciences Corp | Michael A. Mussallem | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.75 per share. | 04 Mar 2024 | 29,350 | 33,835 (0%) | 0% | 36.8 | 1,078,613 | Common Stock |
| Edwards Lifesciences Corp | Michael A. Mussallem | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2024 | 29,350 | 58,700 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Michael A. Mussallem | Director | Sale of securities on an exchange or to another person at price $ 87.05 per share. | 04 Mar 2024 | 16,040 | 4,485 (0%) | 0% | 87.1 | 1,396,282 | Common Stock |
| Edwards Lifesciences Corp | Michael A. Mussallem | Director | Sale of securities on an exchange or to another person at price $ 86.21 per share. | 04 Mar 2024 | 13,310 | 20,525 (0%) | 0% | 86.2 | 1,147,455 | Common Stock |
| Edwards Lifesciences Corp | Michael A. Mussallem | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.75 per share. | 05 Feb 2024 | 29,350 | 33,835 (0%) | 0% | 36.8 | 1,078,613 | Common Stock |
| Edwards Lifesciences Corp | A. Michael Mussallem | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Feb 2024 | 29,350 | 88,050 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | A. Michael Mussallem | Director | Sale of securities on an exchange or to another person at price $ 87.55 per share. | 05 Feb 2024 | 12,167 | 4,485 (0%) | 0% | 87.6 | 1,065,221 | Common Stock |
| Edwards Lifesciences Corp | Mussallem Michael A. | Director | Sale of securities on an exchange or to another person at price $ 86.44 per share. | 05 Feb 2024 | 9,761 | 16,652 (0%) | 0% | 86.4 | 843,741 | Common Stock |
| Edwards Lifesciences Corp | A. Mussallem Michael | Director | Sale of securities on an exchange or to another person at price $ 88.63 per share. | 05 Feb 2024 | 6,422 | 26,413 (0%) | 0% | 88.6 | 569,182 | Common Stock |
| Edwards Lifesciences Corp | Michael A. Mussallem | Director | Sale of securities on an exchange or to another person at price $ 89.61 per share. | 05 Feb 2024 | 1,000 | 32,835 (0%) | 0% | 89.6 | 89,610 | Common Stock |
| Edwards Lifesciences Corp | Michael Mussallem A. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2024 | 29,350 | 117,400 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Michael A. Mussallem | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.75 per share. | 05 Jan 2024 | 29,350 | 33,835 (0%) | 0% | 36.8 | 1,078,613 | Common Stock |
| Edwards Lifesciences Corp | Mussallem Michael A. | Director | Sale of securities on an exchange or to another person at price $ 72.94 per share. | 05 Jan 2024 | 26,850 | 4,485 (0%) | 0% | 72.9 | 1,958,439 | Common Stock |
| Edwards Lifesciences Corp | Mussallem Michael A. | Director | Sale of securities on an exchange or to another person at price $ 73.46 per share. | 05 Jan 2024 | 2,500 | 31,335 (0%) | 0% | 73.5 | 183,650 | Common Stock |
| Edwards Lifesciences Corp | A. Michael Mussallem | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.75 per share. | 13 Dec 2023 | 29,350 | 33,835 (0%) | 0% | 36.8 | 1,078,613 | Common Stock |
| Edwards Lifesciences Corp | A. Michael Mussallem | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Dec 2023 | 29,350 | 146,750 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Mussallem Michael A. | Director | Sale of securities on an exchange or to another person at price $ 75.12 per share. | 13 Dec 2023 | 13,722 | 4,485 (0%) | 0% | 75.1 | 1,030,797 | Common Stock |
| Edwards Lifesciences Corp | A. Michael Mussallem | Director | Sale of securities on an exchange or to another person at price $ 74.22 per share. | 13 Dec 2023 | 10,600 | 18,207 (0%) | 0% | 74.2 | 786,732 | Common Stock |
| Edwards Lifesciences Corp | Mussallem Michael A. | Director | Sale of securities on an exchange or to another person at price $ 73.15 per share. | 13 Dec 2023 | 3,200 | 28,807 (0%) | 0% | 73.2 | 234,080 | Common Stock |
| Edwards Lifesciences Corp | A. Mussallem Michael | Director | Sale of securities on an exchange or to another person at price $ 75.73 per share. | 13 Dec 2023 | 1,828 | 32,007 (0%) | 0% | 75.7 | 138,434 | Common Stock |
| Edwards Lifesciences Corp | Michael A. Mussallem | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 03 Nov 2023 | 371,689 | 0 (0%) | 0% | 0 | Common Stock | |
| Edwards Lifesciences Corp | Michael A. Mussallem | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 03 Nov 2023 | 371,689 | 4,038,377 (1%) | 0% | 0 | Common Stock | |
| Edwards Lifesciences Corp | Michael A. Mussallem | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.75 per share. | 03 Nov 2023 | 29,350 | 33,835 (0%) | 0% | 36.8 | 1,078,613 | Common Stock |
| Edwards Lifesciences Corp | Michael A. Mussallem | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Nov 2023 | 29,350 | 176,100 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Michael A. Mussallem | Director | Sale of securities on an exchange or to another person at price $ 67.18 per share. | 03 Nov 2023 | 29,350 | 4,485 (0%) | 0% | 67.2 | 1,971,733 | Common Stock |
| Edwards Lifesciences Corp | Michael A. Mussallem | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Oct 2023 | 29,350 | 205,450 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Michael A. Mussallem | Director | Sale of securities on an exchange or to another person at price $ 68.84 per share. | 02 Oct 2023 | 29,350 | 4,485 (0%) | 0% | 68.8 | 2,020,454 | Common Stock |
| Edwards Lifesciences Corp | Michael A. Mussallem | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.75 per share. | 02 Oct 2023 | 29,350 | 33,835 (0%) | 0% | 36.8 | 1,078,613 | Common Stock |
| Edwards Lifesciences Corp | Michael A. Mussallem | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Sep 2023 | 29,350 | 234,800 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Michael A. Mussallem | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.75 per share. | 05 Sep 2023 | 29,350 | 33,835 (0%) | 0% | 36.8 | 1,078,613 | Common Stock |
| Edwards Lifesciences Corp | Michael A. Mussallem | Director | Sale of securities on an exchange or to another person at price $ 75.86 per share. | 05 Sep 2023 | 29,350 | 4,485 (0%) | 0% | 75.9 | 2,226,491 | Common Stock |
| Edwards Lifesciences Corp | Michael A. Mussallem | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Aug 2023 | 49,766 | 4,485 (0%) | 0% | 0 | Common Stock | |
| Edwards Lifesciences Corp | Michael A. Mussallem | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Aug 2023 | 49,766 | 3,666,688 (1%) | 0% | 0 | Common Stock | |
| Edwards Lifesciences Corp | Michael A. Mussallem | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Aug 2023 | 29,350 | 264,150 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Michael A. Mussallem | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.75 per share. | 07 Aug 2023 | 29,350 | 83,601 (0%) | 0% | 36.8 | 1,078,613 | Common Stock |
| Edwards Lifesciences Corp | Michael A. Mussallem | Director | Sale of securities on an exchange or to another person at price $ 79.86 per share. | 07 Aug 2023 | 29,050 | 54,251 (0%) | 0% | 79.9 | 2,319,933 | Common Stock |
| Edwards Lifesciences Corp | Michael A. Mussallem | Director | Sale of securities on an exchange or to another person at price $ 80.54 per share. | 07 Aug 2023 | 300 | 83,301 (0%) | 0% | 80.5 | 24,162 | Common Stock |
| Edwards Lifesciences Corp | Michael A. Mussallem | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jul 2023 | 29,350 | 293,500 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Michael A. Mussallem | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.75 per share. | 05 Jul 2023 | 29,350 | 83,601 (0%) | 0% | 36.8 | 1,078,613 | Common Stock |
| Edwards Lifesciences Corp | Michael A. Mussallem | Director | Sale of securities on an exchange or to another person at price $ 90.63 per share. | 05 Jul 2023 | 21,728 | 54,251 (0%) | 0% | 90.6 | 1,969,209 | Common Stock |
| Edwards Lifesciences Corp | Michael A. Mussallem | Director | Sale of securities on an exchange or to another person at price $ 91.22 per share. | 05 Jul 2023 | 7,622 | 75,979 (0%) | 0% | 91.2 | 695,279 | Common Stock |
| Edwards Lifesciences Corp | Michael A. Mussallem | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2023 | 29,350 | 322,850 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Michael A. Mussallem | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.75 per share. | 01 Jun 2023 | 29,350 | 115,559 (0%) | 0% | 36.8 | 1,078,613 | Common Stock |
| Edwards Lifesciences Corp | Michael A. Mussallem | Director | Sale of securities on an exchange or to another person at price $ 84.57 per share. | 01 Jun 2023 | 18,654 | 86,209 (0%) | 0% | 84.6 | 1,577,569 | Common Stock |
| Edwards Lifesciences Corp | Michael A. Mussallem | Director | Sale of securities on an exchange or to another person at price $ 85.08 per share. | 01 Jun 2023 | 5,396 | 104,863 (0%) | 0% | 85.1 | 459,092 | Common Stock |
| Edwards Lifesciences Corp | Michael A. Mussallem | Director | Sale of securities on an exchange or to another person at price $ 83.43 per share. | 01 Jun 2023 | 5,300 | 110,259 (0%) | 0% | 83.4 | 442,179 | Common Stock |
| Edwards Lifesciences Corp | Michael A. Mussallem | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2023 | 4,485 | 86,209 (0%) | 0% | 0 | Common Stock | |
| Edwards Lifesciences Corp | Michael A. Mussallem | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2023 | 3,589 | 3,589 | - | - | Director Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Michael A. Mussallem | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 35.20 per share. | 07 May 2023 | 29,375 | 111,099 (0%) | 0% | 35.2 | 1,033,903 | Common Stock |
| Edwards Lifesciences Corp | Michael A. Mussallem | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 May 2023 | 29,375 | 0 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Michael A. Mussallem | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 May 2023 | 20,777 | 5,698 | - | - | Performance Rights | |
| Edwards Lifesciences Corp | Michael A. Mussallem | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 May 2023 | 20,777 | 81,724 (0%) | 0% | 0 | Common Stock | |
| Edwards Lifesciences Corp | Michael A. Mussallem | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 88.29 per share. | 07 May 2023 | 13,891 | 81,724 (0%) | 0% | 88.3 | 1,226,436 | Common Stock |
| Edwards Lifesciences Corp | Michael A. Mussallem | Director, Chairman & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 07 May 2023 | 9,500 | 95,615 (0%) | 0% | 0 | Common Stock | |
| Edwards Lifesciences Corp | Michael A. Mussallem | Director, Chairman & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 07 May 2023 | 9,500 | 3,616,922 (1%) | 0% | 0 | Common Stock | |
| Edwards Lifesciences Corp | Michael A. Mussallem | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 88.94 per share. | 07 May 2023 | 5,984 | 105,115 (0%) | 0% | 88.9 | 532,217 | Common Stock |
| Edwards Lifesciences Corp | Michael A. Mussallem | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 35.20 per share. | 14 Apr 2023 | 29,375 | 90,322 (0%) | 0% | 35.2 | 1,033,903 | Common Stock |
| Edwards Lifesciences Corp | Michael A. Mussallem | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Apr 2023 | 29,375 | 29,375 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Michael A. Mussallem | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 84.10 per share. | 14 Apr 2023 | 16,059 | 60,947 (0%) | 0% | 84.1 | 1,350,562 | Common Stock |
| Edwards Lifesciences Corp | Michael A. Mussallem | Director, Chairman & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 14 Apr 2023 | 9,500 | 3,607,422 (1%) | 0% | 0 | Common Stock | |
| Edwards Lifesciences Corp | Michael A. Mussallem | Director, Chairman & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 14 Apr 2023 | 9,500 | 77,006 (0%) | 0% | 0 | Common Stock | |
| Edwards Lifesciences Corp | Michael A. Mussallem | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 84.61 per share. | 14 Apr 2023 | 3,816 | 86,506 (0%) | 0% | 84.6 | 322,872 | Common Stock |
| Edwards Lifesciences Corp | Michael A. Mussallem | Director, Chairman & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 15 Feb 2023 | 96,405 | 3,588,422 (1%) | 0% | 0 | Common Stock | |
| Edwards Lifesciences Corp | Michael A. Mussallem | Director, Chairman & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 15 Feb 2023 | 96,405 | 60,947 (0%) | 0% | 0 | Common Stock | |
| Edwards Lifesciences Corp | Michael A. Mussallem | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2023 | 29,375 | 58,750 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Michael A. Mussallem | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 35.20 per share. | 15 Feb 2023 | 29,375 | 90,322 (0%) | 0% | 35.2 | 1,033,903 | Common Stock |
| Edwards Lifesciences Corp | Michael A. Mussallem | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 77.86 per share. | 15 Feb 2023 | 10,700 | 60,947 (0%) | 0% | 77.9 | 833,102 | Common Stock |
| Edwards Lifesciences Corp | Michael A. Mussallem | Director, Chairman & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 15 Feb 2023 | 9,500 | 3,597,922 (1%) | 0% | 0 | Common Stock | |
| Edwards Lifesciences Corp | Michael A. Mussallem | Director, Chairman & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 15 Feb 2023 | 9,500 | 71,647 (0%) | 0% | 0 | Common Stock | |
| Edwards Lifesciences Corp | Michael A. Mussallem | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 77.32 per share. | 15 Feb 2023 | 9,175 | 81,147 (0%) | 0% | 77.3 | 709,411 | Common Stock |
| Edwards Lifesciences Corp | Michael A. Mussallem | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 35.20 per share. | 14 Feb 2023 | 29,375 | 186,727 (0%) | 0% | 35.2 | 1,033,903 | Common Stock |
| Edwards Lifesciences Corp | Michael A. Mussallem | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2023 | 29,375 | 88,125 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Michael A. Mussallem | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 76.83 per share. | 14 Feb 2023 | 16,275 | 157,352 (0%) | 0% | 76.8 | 1,250,408 | Common Stock |
| Edwards Lifesciences Corp | Michael A. Mussallem | Director, Chairman & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 14 Feb 2023 | 9,500 | 173,627 (0%) | 0% | 0 | Common Stock | |
| Edwards Lifesciences Corp | Michael A. Mussallem | Director, Chairman & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 14 Feb 2023 | 9,500 | 3,492,017 (1%) | 0% | 0 | Common Stock | |
| Edwards Lifesciences Corp | Michael A. Mussallem | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 77.75 per share. | 14 Feb 2023 | 3,600 | 183,127 (0%) | 0% | 77.8 | 279,900 | Common Stock |
| Edwards Lifesciences Corp | Michael A. Mussallem | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 35.20 per share. | 13 Jan 2023 | 29,375 | 186,727 (0%) | 0% | 35.2 | 1,033,903 | Common Stock |
| Edwards Lifesciences Corp | Michael A. Mussallem | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2023 | 29,375 | 117,500 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Michael A. Mussallem | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 78.09 per share. | 13 Jan 2023 | 19,875 | 157,352 (0%) | 0% | 78.1 | 1,552,124 | Common Stock |
| Edwards Lifesciences Corp | Michael A. Mussallem | Director, Chairman & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 13 Jan 2023 | 9,500 | 177,227 (0%) | 0% | 0 | Common Stock | |
| Edwards Lifesciences Corp | Michael A. Mussallem | Director, Chairman & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 13 Jan 2023 | 9,500 | 3,482,517 (1%) | 0% | 0 | Common Stock | |
| Edwards Lifesciences Corp | Michael A. Mussallem | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 35.20 per share. | 14 Dec 2022 | 29,375 | 186,727 (0%) | 0% | 35.2 | 1,033,903 | Common Stock |
| Edwards Lifesciences Corp | Michael A. Mussallem | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Dec 2022 | 29,375 | 146,875 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Michael A. Mussallem | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 76.04 per share. | 14 Dec 2022 | 12,155 | 157,352 (0%) | 0% | 76.0 | 924,266 | Common Stock |
| Edwards Lifesciences Corp | Michael A. Mussallem | Director, Chairman & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 14 Dec 2022 | 9,500 | 3,473,017 (1%) | 0% | 0 | Common Stock | |
| Edwards Lifesciences Corp | Michael A. Mussallem | Director, Chairman & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 14 Dec 2022 | 9,500 | 169,507 (0%) | 0% | 0 | Common Stock | |
| Edwards Lifesciences Corp | Michael A. Mussallem | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 76.93 per share. | 14 Dec 2022 | 7,420 | 179,007 (0%) | 0% | 76.9 | 570,821 | Common Stock |
| Edwards Lifesciences Corp | Michael A. Mussallem | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 77.51 per share. | 14 Dec 2022 | 300 | 186,427 (0%) | 0% | 77.5 | 23,253 | Common Stock |
| Edwards Lifesciences Corp | Michael A. Mussallem | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Nov 2022 | 29,375 | 176,250 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Michael A. Mussallem | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 35.20 per share. | 14 Nov 2022 | 29,375 | 186,727 (0%) | 0% | 35.2 | 1,033,903 | Common Stock |
| Edwards Lifesciences Corp | Michael A. Mussallem | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 73.94 per share. | 14 Nov 2022 | 15,575 | 157,352 (0%) | 0% | 73.9 | 1,151,616 | Common Stock |